title: Pharmacoepidemiological considerations in observed-to-expected analyses for vaccines.
authors.affiliation: Vaccine Clinical Safety and Pharmacovigilance, GSK Vaccines, Wavre, Belgium.
authors.forename: Olivia
authors.initials: O
authors.lastname: Mahaux
authors.affiliation: Vaccine Clinical Safety and Pharmacovigilance, GSK Vaccines, Wavre, Belgium.
authors.forename: Vincent
authors.initials: V
authors.lastname: Bauchau
authors.affiliation: Vaccine Clinical Safety and Pharmacovigilance, GSK Vaccines, Wavre, Belgium.
authors.forename: Lionel
authors.identifier: http://orcid.org/0000-0001-7354-6475
authors.initials: L
authors.lastname: Van Holle
mesh_terms: D000818:Animals; D003627:Data Interpretation, Statistical; D057225:Data Mining / Q000379:methods; D006801:Humans; D015994:Incidence; D017891:Pharmacoepidemiology / Q000379:methods*; D035501:Uncertainty; D014612:Vaccines / Q000009:adverse effects*
chemical_list: D014612:Vaccines
keywords: Observed-to-expected; methodology; pharmacoepidemiology; uncertainty analyses